19506220

Source:http://linkedlifedata.com/resource/pubmed/id/19506220

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0205210, umls-concept:C0254119, umls-concept:C0360714, umls-concept:C0442117, umls-concept:C0871261, umls-concept:C1280500, umls-concept:C1521991, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	23
pubmed:dateCreated	2009-6-9
pubmed:abstractText	Findings from a small clinical study suggested that statins may counteract the therapeutic effects of interferon beta (IFNbeta) in patients with relapsing-remitting multiple sclerosis (RRMS).
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/M01 RR-018390, http://linkedlifedata.com/resource/pubmed/grant/P01 NS38667
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19506220-10790367, http://linkedlifedata.com/resource/pubmed/commentcorrection/19506220-12396716, http://linkedlifedata.com/resource/pubmed/commentcorrection/19506220-12422206, http://linkedlifedata.com/resource/pubmed/commentcorrection/19506220-12422218, http://linkedlifedata.com/resource/pubmed/commentcorrection/19506220-16286171, http://linkedlifedata.com/resource/pubmed/commentcorrection/19506220-16510745, http://linkedlifedata.com/resource/pubmed/commentcorrection/19506220-17892398, http://linkedlifedata.com/resource/pubmed/commentcorrection/19506220-18525027, http://linkedlifedata.com/resource/pubmed/commentcorrection/19506220-8798467
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Interferon-beta, http://linkedlifedata.com/resource/pubmed/chemical/interferon beta 1a
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1526-632X
pubmed:author	pubmed-author:AppachiSS, pubmed-author:CalabresiP APA, pubmed-author:ConfavreuxCC, pubmed-author:GalettaS LSL, pubmed-author:HydeRR, pubmed-author:LublinF DFD, pubmed-author:MaurerS LSL, pubmed-author:PaceAA, pubmed-author:PanzaraMM, pubmed-author:RadueE-WEW, pubmed-author:RaniM R SMR, pubmed-author:RansohoffR MRM, pubmed-author:RudickR ARA, pubmed-author:ShrockJJ
pubmed:issnType	Electronic
pubmed:day	9
pubmed:volume	72
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1989-93
pubmed:dateRevised	2010-9-27
pubmed:meshHeading	pubmed-meshheading:19506220-Adjuvants, Immunologic, pubmed-meshheading:19506220-Adult, pubmed-meshheading:19506220-Cell Line, Tumor, pubmed-meshheading:19506220-Central Nervous System, pubmed-meshheading:19506220-Disease Progression, pubmed-meshheading:19506220-Drug Interactions, pubmed-meshheading:19506220-Drug Toxicity, pubmed-meshheading:19506220-Female, pubmed-meshheading:19506220-Humans, pubmed-meshheading:19506220-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:19506220-Hyperlipidemias, pubmed-meshheading:19506220-Injections, Intramuscular, pubmed-meshheading:19506220-Interferon-beta, pubmed-meshheading:19506220-Jurkat Cells, pubmed-meshheading:19506220-Magnetic Resonance Imaging, pubmed-meshheading:19506220-Male, pubmed-meshheading:19506220-Middle Aged, pubmed-meshheading:19506220-Multiple Sclerosis, pubmed-meshheading:19506220-Muscle, Skeletal, pubmed-meshheading:19506220-Prospective Studies, pubmed-meshheading:19506220-Recurrence, pubmed-meshheading:19506220-Treatment Outcome
pubmed:year	2009
pubmed:articleTitle	Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a.
pubmed:affiliation	Mellen Center for Treatment and Research in Multiple Sclerosis, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. rudickr@ccf.org
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural